MUHAMID ASIF

Allopathic & Osteopathic Physicians|Family Medicine FREMONT, OH NPI 1265093363

General Payments — all program years on this page

$710.42

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 44
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $366.90 across 23 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $366.9023

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $215.3914
Novo Nordisk AS $76.515
Acerta Pharma LLC $32.222
PFIZER INC. $21.851
Abbott Laboratories $20.931

By program year

Program yearAmountRecords
2023 $343.5221
2024 $366.9023

Records — PY2024 (23)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096586620 Novo Nordisk Inc $14.38 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096902927 Novo Nordisk Inc $13.60 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097029752 Novo Nordisk Inc $15.38 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097351995 Novo Nordisk Inc $18.15 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097509745 Novo Nordisk Inc $15.00 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247187 ABBVIE INC. $13.51 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247189 ABBVIE INC. $18.11 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247191 ABBVIE INC. $16.99 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247193 ABBVIE INC. $23.19 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247195 ABBVIE INC. $5.73 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247197 ABBVIE INC. $23.14 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247199 ABBVIE INC. $13.65 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247201 ABBVIE INC. $5.80 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247203 ABBVIE INC. $25.28 08/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247205 ABBVIE INC. $6.98 09/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247207 ABBVIE INC. $11.61 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247209 ABBVIE INC. $20.48 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247211 ABBVIE INC. $4.82 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103247213 ABBVIE INC. $26.10 12/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104459922 AstraZeneca Pharmaceuticals LP $18.61 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105761568 AstraZeneca Pharmaceuticals LP $13.61 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124932892 Abbott Laboratories $20.93 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131852997 PFIZER INC. $21.85 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.